Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.

Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira À, Evangelou N, Wuerfel J; MAGNIMS Study Group.

JAMA Neurol. 2019 Aug 19. doi: 10.1001/jamaneurol.2019.2478. [Epub ahead of print]

PMID:
31424490
2.

Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.

Maggi P, Absinta M, Grammatico M, Vuolo L, Emmi G, Carlucci G, Spagni G, Barilaro A, Repice AM, Emmi L, Prisco D, Martinelli V, Scotti R, Sadeghi N, Perrotta G, Sati P, Dachy B, Reich DS, Filippi M, Massacesi L.

Ann Neurol. 2018 Feb;83(2):283-294. doi: 10.1002/ana.25146. Epub 2018 Feb 15.

3.

The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.

Samaraweera AP, Clarke MA, Whitehead A, Falah Y, Driver ID, Dineen RA, Morgan PS, Evangelou N.

J Neuroimaging. 2017 Jan;27(1):114-121. doi: 10.1111/jon.12367. Epub 2016 Jun 14.

PMID:
27300318
4.

The "central vein sign" in patients with diagnostic "red flags" for multiple sclerosis: A prospective multicenter 3T study.

Maggi P, Absinta M, Sati P, Perrotta G, Massacesi L, Dachy B, Pot C, Meuli R, Reich DS, Filippi M, Pasquier RD, Théaudin M.

Mult Scler. 2019 Sep 19:1352458519876031. doi: 10.1177/1352458519876031. [Epub ahead of print]

PMID:
31536435
5.

Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.

Sinnecker T, Mittelstaedt P, Dörr J, Pfueller CF, Harms L, Niendorf T, Paul F, Wuerfel J.

Arch Neurol. 2012 Jun;69(6):739-45. doi: 10.1001/archneurol.2011.2450.

PMID:
22351849
6.

Multiple sclerosis: High prevalence of the 'central vein' sign in white matter lesions on susceptibility-weighted images.

Sparacia G, Agnello F, Gambino A, Sciortino M, Midiri M.

Neuroradiol J. 2018 Aug;31(4):356-361. doi: 10.1177/1971400918763577. Epub 2018 Mar 22.

7.

Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients.

Kalinowska-Lyszczarz A, Pawlak MA, Pietrzak A, Pawlak-Bus K, Leszczynski P, Puszczewicz M, Paprzycki W, Kozubski W, Michalak S.

Lupus. 2018 Sep;27(10):1624-1635. doi: 10.1177/0961203318781004. Epub 2018 Jun 27.

PMID:
29950159
8.

The Central Vein Sign in Radiologically Isolated Syndrome.

Suthiphosuwan S, Sati P, Guenette M, Montalban X, Reich DS, Bharatha A, Oh J.

AJNR Am J Neuroradiol. 2019 May;40(5):776-783. doi: 10.3174/ajnr.A6045. Epub 2019 Apr 18.

PMID:
31000526
9.

Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD.

Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, De Angelis F, Yiannakas MC, Prados F, Ourselin S, Yousry TA, Barkhof F, Ciccarelli O.

Neurology. 2018 Apr 3;90(14):e1183-e1190. doi: 10.1212/WNL.0000000000005256. Epub 2018 Mar 7.

PMID:
29514948
10.

FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?

Campion T, Smith RJP, Altmann DR, Brito GC, Turner BP, Evanson J, George IC, Sati P, Reich DS, Miquel ME, Schmierer K.

Eur Radiol. 2017 Oct;27(10):4257-4263. doi: 10.1007/s00330-017-4822-z. Epub 2017 Apr 13.

11.

Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.

Bensi C, Marrodan M, González A, Chertcoff A, Osa Sanz E, Chaves H, Schteinschnaider A, Correale J, Farez MF.

Mult Scler Relat Disord. 2018 Oct;25:246-250. doi: 10.1016/j.msard.2018.08.008. Epub 2018 Aug 9.

PMID:
30144694
12.

Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.

Harrison DM, Roy S, Oh J, Izbudak I, Pham D, Courtney S, Caffo B, Jones CK, van Zijl P, Calabresi PA.

JAMA Neurol. 2015 Sep;72(9):1004-12. doi: 10.1001/jamaneurol.2015.1241.

13.

"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine.

Solomon AJ, Schindler MK, Howard DB, Watts R, Sati P, Nickerson JP, Reich DS.

Ann Clin Transl Neurol. 2015 Dec 16;3(2):82-7. doi: 10.1002/acn3.273. eCollection 2016 Feb.

14.

Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain.

Mistry N, Dixon J, Tallantyre E, Tench C, Abdel-Fahim R, Jaspan T, Morgan PS, Morris P, Evangelou N.

JAMA Neurol. 2013 May;70(5):623-8. doi: 10.1001/jamaneurol.2013.1405.

PMID:
23529352
15.

Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm.

Solomon AJ, Watts R, Ontaneda D, Absinta M, Sati P, Reich DS.

Mult Scler. 2018 May;24(6):750-757. doi: 10.1177/1352458517726383. Epub 2017 Aug 18.

16.

Alemtuzumab for multiple sclerosis.

Riera R, Porfírio GJ, Torloni MR.

Cochrane Database Syst Rev. 2016 Apr 15;4:CD011203. doi: 10.1002/14651858.CD011203.pub2. Review.

17.

Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis.

Wuerfel J, Sinnecker T, Ringelstein EB, Jarius S, Schwindt W, Niendorf T, Paul F, Kleffner I, Dörr J.

Mult Scler. 2012 Nov;18(11):1592-9. doi: 10.1177/1352458512441270. Epub 2012 Jun 18.

PMID:
22711711
18.

The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?

Kau T, Taschwer M, Deutschmann H, Schönfelder M, Weber JR, Hausegger KA.

Eur Radiol. 2013 Jul;23(7):1956-62. doi: 10.1007/s00330-013-2791-4. Epub 2013 Feb 22.

PMID:
23436147
19.

Functional brain imaging: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2006;6(22):1-79. Epub 2006 Dec 1.

20.

Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.

La Mantia L, Di Pietrantonj C, Rovaris M, Rigon G, Frau S, Berardo F, Gandini A, Longobardi A, Weinstock-Guttman B, Vaona A.

Cochrane Database Syst Rev. 2016 Nov 24;11:CD009333. Review.

Supplemental Content

Support Center